WHO ICTRP trial
A randomized, two-armed, single-blind, parallel, active controlled, and…
CTIS2024-515557-22-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-515557-22-00 |
|---|---|
| Public title | A randomized, two-armed, single-blind, parallel, active controlled, and non-inferiority clinical trial to Compare Efficacy and Safety of anti TNF-alfa biosimilar molecules to the originators in children with active Juvenile Idiopathic Arthritis |
| Scientific title | A randomized, two-armed, single-blind, parallel, active controlled, and non-inferiority clinical trial to Compare Efficacy and Safety of anti TNF-alfa biosimilar molecules to the originators in children with active Juvenile Idiopathic Arthritis |
| Primary sponsor | Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Italy |
| Conditions | Juvenile Idiopathic Arthritis MedDRA version: 23.1Level: PTClassification code: 10059176Term: Juvenile idiopathic arthritis Class: 100000004859;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] |
| Interventions | Product Name: ADALIMUMAB, Product Code:SUB20016, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: Humira 20 mg solution for injection in pre-filled syringe, Product Code:PRD5952375… |
| Registration date | Jul 19, 2024 |
| Target size | 290 |
| Secondary IDs | 2021-004031-86 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: